Your browser doesn't support javascript.
loading
Methazolamide Associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Female of Caucasian Descent.
Baluch, Amarah; Chohan, Moeed R; Warda, Katerina; Sippy, Rishab; Sandhu, Jasmine.
Afiliação
  • Baluch A; Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.
  • Chohan MR; Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.
  • Warda K; Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.
  • Sippy R; Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.
  • Sandhu J; Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.
Cureus ; 14(2): e21864, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35155038
Stevens-Johnson syndrome (SJS) is a potentially life-threatening cutaneous disorder that is characterized by skin erosions. It lies on a spectrum of varying severity with toxic epidermal necrolysis (TEN) being the most severe form. An overlap of the syndromes is known as SJS/TEN. These disorders are most often caused by a drug reaction, with anti-epileptic drugs and sulfonamide drugs as the common offending agents. Rarely, the syndrome can be due to a reaction to carbonic anhydrase inhibitors such as methazolamide. When present in association with methazolamide, the syndrome has only been known to occur in patients of Asian descent with human leukocyte antigen (HLA) mutations. We present a case of methazolamide-associated Stevens-Johnson syndrome in a patient of Caucasian descent.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article